Granules India Limited — Azathioprine Exporter Profile
Indian Pharmaceutical Exporter · #5 for Azathioprine · $1.4M export value · DGFT Verified
Granules India Limited is the #5 Indian exporter of Azathioprine with $1.4M in export value and 39 verified shipments. Granules India Limited holds a 4.0% market share in Azathioprine exports across 3 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.
Granules India Limited — Azathioprine Export Profile: Buyers & Destinations
Where Does Granules India Limited Export Azathioprine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $525.0K | 13 | 63.0% |
| NETHERLANDS | $288.5K | 20 | 34.6% |
| IRELAND | $19.3K | 6 | 2.3% |
Granules India Limited exports Azathioprine to 3 countries. The largest destination is FRANCE accounting for 63.0% of Granules India Limited's Azathioprine shipments, followed by NETHERLANDS (34.6%) and IRELAND (2.3%). These destinations reflect Granules India Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Azathioprine from Granules India Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CSP VIATRIS SANTE AT CSP-LAB | FRANCE | $280.9K | 7 |
| CSP VIATRIS SANTE AT CSP-LAB. | FRANCE | $150.2K | 4 |
| CSP P/O VIATRIS SANTE LABO 274 | FRANCE | $93.9K | 2 |
| MYLAN IRELAND LTD, | NETHERLANDS | $93.0K | 10 |
| MYLAN IRELAND LTD | NETHERLANDS | $68.1K | 2 |
| MYLAN B.V. | NETHERLANDS | $62.9K | 4 |
| MYLAN IRELAND LIMITED | NETHERLANDS | $53.5K | 2 |
| UNITED DRUG DISTRIBUTORS | IRELAND | $19.3K | 6 |
| MYLAN IRELAND LIMITED. | NETHERLANDS | $11.1K | 2 |
Granules India Limited supplies Azathioprine to 9 buyers globally. The largest buyer is CSP VIATRIS SANTE AT CSP-LAB (FRANCE), followed by CSP VIATRIS SANTE AT CSP-LAB. (FRANCE) and CSP P/O VIATRIS SANTE LABO 274 (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Azathioprine Export Value and How Much Does Granules India Limited Contribute?
India exported $23.0M worth of Azathioprine through 886 shipments from 134 suppliers to 68 countries, serving 203 buyers globally. Granules India Limited contributes $1.4M to this total, accounting for 4.0% of India's Azathioprine exports. Granules India Limited ships Azathioprine to 3 countries through 9 buyers.
What Is the Average Shipment Value for Granules India Limited's Azathioprine Exports?
Granules India Limited's average Azathioprine shipment value is $35.0K per consignment, based on 39 shipments totaling $1.4M. The largest destination is FRANCE (63.0% of Granules India Limited's Azathioprine exports).
How Does Granules India Limited Compare to Other Indian Azathioprine Exporters?
Granules India Limited ranks #5 among 134 Indian Azathioprine exporters with a 4.0% market share. The top 3 exporters are RPG LIFE SCIENCES LIMITED ($12.1M), ZYDUS LIFESCIENCES LIMITED ($5.1M), AMNEAL PHARMACEUTICALS PRIVATE LIMITED ($3.0M). Granules India Limited processed 39 shipments to 3 destination countries.
What Azathioprine Formulations Does Granules India Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AZATHIOPRINE MYLAN 50MG,10 X10S-MYLAN/FR(29028 PACKS X100BL) | $126.6K | 3 |
| AZATHIOPRINE VIATRIS 50MG,10X10S-VIATRIS/FRANCE AZATHIOPRINE TAB 50MG 100BL FR MY (38532 PACKS X 100BL) | $50.0K | 1 |
| AZATHIOPRINE MYLAN 50MG,10 X 10S-MYLAN /FR AZATHIOPRINE TAB 50MG 100BL FR MY (52405.08 PACKS X100BL) | $50.0K | 1 |
| AZATHIOPRINE MYLAN 50MG,3 X 10S-MYLAN /NL AZATHIOPRINE TAB 50MG 30BL NL MY (60886 PACKS X30BL) | $50.0K | 1 |
| AZATHIOPRINE VIATRIS 50MG,10X10S-VIATRIS/FRANCE AZATHIOPRINE TAB 50MG 100BL FR MY (19416 PACKS X 100BL) | $50.0K | 1 |
| AZATHIOPRINE 50MG,10X10S-VIATRIS/DZ AZATHIOPRINE TAB 50MG 100BL DZ MY (29184 PACKS X 100BL) | $50.0K | 1 |
| AZATHIOPRINE VIATRIS 50 MG 10 X 10S-VIARTIS/FRANCE (AZATHIPRINE TAB 50 MG 100BLFR MY) - (29106 PAC X 100BL) | $50.0K | 1 |
| AZATHIOPRINE TAB 50MG 17942 X 100 PACK 1794200 NOS | $50.0K | 1 |
| AZATHIOPRINE 50MG 10X10S-VIATRIS/DZ (AZATHIPRINE TAB 50MG 100BL DZ MY) - (9702 PAC X 100BL0 | $43.9K | 1 |
| AZATHIOPRINE MYLAN 50MG,10X10S-MYLAN/FRAZATHIOPRINE TAB 50MG 100BL FR MY (9630PACKS X 100BL) | $41.8K | 1 |
Granules India Limited exports 27 distinct Azathioprine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AZATHIOPRINE MYLAN 50MG,10 X10S-MYLAN/FR(29028 PACKS X100BL) with 3 shipments worth $126.6K.
How Does Granules India Limited Compare to Nearest Azathioprine Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | ZYDUS LIFESCIENCES LIMITED | $5.1M | 102 | 1 | $50.0K |
| 3 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $3.0M | 60 | 1 | $50.0K |
| 5 | GRANULES INDIA LIMITED ★ | $1.4M | 39 | 3 | $35.0K |
| 7 | ALKEM LABORATORIES LIMITED | $413.9K | 15 | 3 | $27.6K |
| 4 | CADILA HEALTHCARE LIMITED | $300.0K | 6 | 1 | $50.0K |
Granules India Limited ranks #5 among 134 Indian Azathioprine exporters. Average shipment value of $35.0K compared to the market average of $171.8K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and AMNEAL PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Azathioprine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 162 | 18.3% |
| SAHAR AIR | 130 | 14.7% |
| MUNDRA SEA | 80 | 9.0% |
| NHAVA SHEVA SEA (INNSA1) | 79 | 8.9% |
| DELHI AIR | 44 | 5.0% |
| Bombay Air | 39 | 4.4% |
| MUNDRA SEA (INMUN1) | 38 | 4.3% |
| DELHI AIR CARGO ACC (INDEL4) | 38 | 4.3% |
Geopolitical & Trade Policy Impact on Granules India Limited's Azathioprine Exports
Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)
The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.
Granules India Limited — Regulatory Compliance & Quality Standards
Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)
Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)
About Granules India Limited
Granules India Limited exports 20 products worth $412.3M. Beyond Azathioprine, top products include Metformin, Acetaminophen, Amino, Ibuprofen, Potassium. View the complete Granules India Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azathioprine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azathioprine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 39 individual customs records matching Granules India Limited exporting Azathioprine, covering 27 formulations to 3 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 68+ countries, 203+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azathioprine Export Data from Granules India Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Granules India Limited's Azathioprine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Granules India Limited
Full Company Profile →
20 products · $412.3M total trade · 9 categories
Azathioprine Stats
Company Overview
Top Products by Granules India Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Granules India Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azathioprine. For current shipment-level data, contact TransData Nexus.